玩股撇步(動畫小學堂)  

  • 營業利益和稅後淨利成長率大於營收成長率, 通常代表公司在成長, 如果是漲很多的股票, 發現沒有這個現象就要留意了
  • 營收到某個數字後, 營業利益產生不成比例的增加, 有可能是規模經濟的效應
  • 如果是有淡旺季的公司, 是否有淡季不淡, 旺季更旺的情況
  • 漲很多的股票要留意 EPS 較上季是否有大幅衰退的情況
  • 如果EPS衰退,要觀察同業是不是有一樣的狀況
  • 要留意增資減資和公司債對股本及EPS的影響
成長能力-近20季
加權平均股數 QoQ YoYEPS QoQ YoY本業EPS QoQ YoY累計EPS QoQ YoY營收 QoQ YoY毛利率(%) QoQ YoY營業利益 QoQ YoY稅後淨利 QoQ YoY稅前淨利率(%) QoQ YoY稅後淨利率(%) QoQ YoY兩季平均(YOY)營收成長率(%)兩季平均(YOY)EPS成長率(%)兩季平均(YOY)本業EPS成長率(%)
23Q4 (20)670.01.520.59-27.1631.110.7624.5938.182.6627.8824.32.03-1.4626.8876.526.847.520.615.1741.860.39-29.0930.024.30-30.856.4919.35-26.954.715.55-10.989.95
23Q3 (19)670.01.520.815.1917.390.61-4.691.672.0865.0823.082.0612.5724.8571.621.945.110.5848.7213.730.557.8419.5735.1438.841.326.49-5.16-4.0932.5329.5912.96
23Q2 (18)671.521.520.7754.028.330.6430.61392.311.26152.024.751.8352.538.6470.264.938.060.39-7.1456.00.5154.5527.525.31-27.1-39.3827.932.57-6.8713.7532.559.85
23Q1 (17)660.00.00.5011.1121.950.49-10.9175.00.50-76.6421.951.2-25.020.066.96-5.9212.440.42-2.33162.50.3310.022.2234.7252.1541.2527.2347.351.34-14.02-11.84-9.62
22Q4 (16)660.00.00.45-34.7818.420.55-8.3348.652.1426.6338.961.6-3.0314.2971.174.453.810.43-15.6934.380.3-34.7820.022.82-34.220.8418.48-33.092.1610.98-9.89176.61
22Q3 (15)660.00.00.6915.0130.00.60361.5493.551.6967.3346.961.6525.029.9268.144.87.630.51104.096.150.4615.0130.034.69-16.9175.5627.62-7.975.0328.5030.67153.99
22Q2 (14)660.08.20.6046.3415.380.13-53.57-75.01.01146.349.781.3232.03.9465.029.19-1.040.2556.25-19.350.448.1525.041.7569.8588.0629.9911.6120.251.7127.12-38.95
22Q1 (13)660.08.20.417.892.50.28-24.32-30.00.41-73.382.51.0-28.57-9.9159.55-13.14-19.020.16-50.0-51.520.278.08.024.588.62-11.926.8748.5421.31-9.1617.28-2.48
21Q4 (12)660.08.20.3826.67-34.480.3719.35-31.481.5433.91-26.671.410.246.0668.568.29-10.120.3223.08-28.890.2525.0-28.5722.6314.52-32.0818.0914.64-32.375.12-7.82-10.52
21Q3 (11)668.28.20.30-42.31-46.430.31-40.38-32.611.1525.0-24.341.270.04.9663.31-3.64-14.990.26-16.13-29.730.2-37.5-41.1819.76-10.99-40.5415.78-36.73-43.867.21-6.16-5.19
21Q2 (10)610.05.170.5230.033.330.5230.085.710.92130.0-8.911.2714.4122.1265.70-10.66-6.640.31-6.0629.170.3228.045.4522.20-20.43-14.9824.9412.616.05-0.75-0.522.04
21Q1 (9)610.05.170.40-31.03-36.510.40-25.93-23.080.40-80.95-36.511.11-15.910.9173.54-3.591.90.33-26.67-17.50.25-28.57-30.5627.90-16.27-25.5222.15-17.2-33.02-3.41-13.73-4.27
20Q4 (8)610.05.170.583.57-15.940.5417.39-11.482.1038.160.481.329.091.5476.282.430.360.4521.62-4.260.352.94-12.533.320.27-5.6426.75-4.84-12.8912.7223.5840.84
20Q3 (7)615.175.170.5643.5927.270.4664.2917.951.5250.58.571.2116.3517.4874.475.837.60.3754.1732.140.3454.5530.7733.2327.2721.928.1130.8112.535.452.759.07
20Q2 (6)580.00.00.39-38.1-11.360.28-46.15-24.321.0160.326.321.04-5.452.9770.37-2.494.950.24-40.0-22.580.22-38.89-12.026.11-30.3-14.2821.49-35.02-14.65-10.42-23.40-30.45
20Q1 (5)580.01.750.63-8.718.870.52-14.7520.930.63-69.8618.871.1-15.385.7772.17-5.0510.790.4-14.8937.930.36-10.020.037.466.0931.6733.077.6815.99--0.00
19Q4 (4)580.00.00.6956.820.00.6156.410.02.0949.290.01.326.210.076.019.830.00.4767.860.00.453.850.035.3129.530.030.7122.940.0--0.00
19Q3 (3)580.00.00.440.00.00.395.410.01.4047.370.01.031.980.069.213.220.00.28-9.680.00.264.00.027.26-10.510.024.98-0.790.0--0.00
19Q2 (2)581.750.00.44-16.980.00.37-13.950.00.9579.250.01.01-2.880.067.052.930.00.316.90.00.25-16.670.030.467.070.025.18-11.680.0--0.00
19Q1 (1)570.00.00.530.00.00.430.00.00.530.00.01.040.00.065.140.00.00.290.00.00.30.00.028.450.00.028.510.00.0--0.00
年/月營收月增率(%)去年同期年增率(%)累計營收累計營收年增率(%)近三月累計營收存貨銷售比備註(年增率變動50%需說明原因)
2024/20.51-31.96108.21.25108.012.06N/A可吸收防沾黏凝膠及關節腔注射劑業務銷售增加
2024/10.74-8.5107.890.74107.892.17N/A可吸收防沾黏凝膠、關節腔注射劑及膀胱灌注液業務銷售增加。
2023/120.8130.7925.557.1327.922.030.43-
2023/110.623.3740.476.3228.231.790.49-
2023/100.65.8917.595.727.031.970.44-
2023/90.57-29.58-16.155.128.242.060.46-
2023/80.8116.81107.794.5337.342.210.43可吸收防沾黏凝膠、關節腔注射劑及皮下填補劑業務銷售增加。
2023/70.69-3.2117.693.7327.962.020.46-
2023/60.7114.7225.733.0430.551.830.52-
2023/50.6224.0942.172.3232.11.720.55-
2023/40.5-17.1856.581.728.781.350.71可吸收防沾黏凝膠及關節腔注射劑業務銷售增加。
2023/30.6148.825.971.219.931.20.81-
2023/20.24-32.063.960.638.261.250.78-
2023/10.36-44.7478.210.3678.211.450.67皮下填補劑業務銷售增加。
2022/120.6546.34-5.295.5710.241.60.6-
2022/110.44-13.4616.814.9312.671.630.59-
2022/100.51-24.4949.434.4912.281.570.61-
2022/90.6874.5264.523.978.81.650.59關節腔注射劑及可吸收防沾黏凝膠業務銷售增加。
2022/80.39-33.83-29.743.31.741.540.64-
2022/70.593.488.672.918.191.590.62可吸收防沾黏凝膠、皮下填補劑及關節腔注射劑業務銷售增加。
2022/60.5729.724.932.33-2.291.320.64-
2022/50.4436.662.891.76-4.411.330.64-
2022/40.32-43.944.971.32-6.591.120.76-
2022/30.57144.1-1.21.0-9.761.00.81-
2022/20.2316.452.660.43-18.981.120.73-
2022/10.2-70.63-34.960.2-34.961.260.64-
2021/120.6880.535.295.068.281.40.59-
2021/110.3810.724.024.375.01.130.73-
2021/100.34-16.87-32.993.993.51.30.64-
2021/90.41-25.4772.33.659.061.270.53關節腔注射劑及可吸收防沾黏業務銷售增加。
2021/80.5577.67-21.443.244.211.40.49-
2021/70.31-42.4815.292.6911.681.270.53-
2021/60.5427.217.582.3811.231.270.42-
2021/50.4239.4266.631.8412.351.310.41皮下填補劑、關節腔注射劑及可吸收防沾黏業務銷售增加。
2021/40.3-47.256.491.422.361.110.48-
2021/30.58153.6715.911.111.291.110.39-
2021/20.23-26.2213.40.54-10.821.040.41-
2021/10.31-38.91-22.960.31-22.961.120.38-
2020/120.565.46-3.544.676.621.320.35-
2020/110.3-40.19-21.834.168.01.050.44-
2020/100.51113.7632.443.8611.361.450.32-
2020/90.24-66.02-24.193.358.721.210.35-
2020/80.7160.77118.363.1112.471.470.29皮下填補劑、一針劑型關節腔注射劑及可吸收防沾黏業務銷售增加
2020/70.27-46.33-31.342.41-1.451.030.41-
2020/60.597.035.882.144.261.040.3-
2020/50.25-10.89-16.11.643.771.040.3-
2020/40.29-42.5823.641.388.50.980.32-
2020/30.5148.1836.021.15.151.10.26-
2020/20.2-49.89-11.00.6-11.491.120.26-
2020/10.4-23.51-11.740.4-11.741.310.22-
2019/120.5234.0926.694.3832.851.30.25-
2019/110.391.3313.33.8633.731.090.3-
2019/100.3822.3548.513.4736.511.020.32-
2019/90.31-2.1241.253.0835.141.030.35-
2019/80.32-18.0144.122.7734.481.190.3-
2019/70.39-17.2337.172.4433.311.170.31-
2019/60.4756.12154.982.0532.591.010.33皮下填補劑、可吸收防沾黏業務銷售增加及IFRS 15合約客戶收入,因原贈針認列遞延收入,實際出庫認列營業收入。
2019/50.331.3180.691.5815.90.90.37皮下填補劑及可吸收防沾黏業務銷售增加
2019/40.23-36.8350.631.286.790.0N/A皮下填補劑業務銷售增加
2019/30.3762.388.421.040.330.0N/A-
成長能力-近10年
加權平均股數 YoYEPS YoY本業EPS YoY營收 YoY毛利率(%) YoY營業利益 YoY稅前淨利 YoY稅後淨利 YoY
2023 (10)671.522.4125.522.5162.997.1328.0171.887.732.048.152.120.691.7825.35
2022 (9)660.01.9227.151.54-4.355.5710.0866.72-1.331.3510.661.7450.01.4239.22
2021 (8)668.21.51-25.981.61-11.545.068.3567.62-8.041.22-17.011.16-23.681.02-20.31
2020 (7)615.172.040.991.820.554.676.6273.535.41.479.71.5213.431.285.79
2019 (6)5811.542.0221.691.8161.614.3832.7369.765.991.3465.431.3444.091.2139.08
2018 (5)520.01.66403.031.12202.73.327.9165.8211.30.81161.290.93304.350.87411.76
2017 (4)520.00.3300.37-24.492.5813.1659.146.180.3110.710.2300.170
2016 (3)520.0-0.5100.49-31.942.28-13.9655.70-5.180.28-30.0-0.310-0.260
2015 (2)52-3.71.0400.7202.6567.7258.7416.970.400.4700.550
2014 (1)5425.58-0.410-0.5201.58-21.3950.220-0.350-0.220-0.220

財務分析相關資訊

免責聲明

本網站所有資料僅供參考,如使用者依本資料交易發生交易損失需自行負責,本網站對資料內容錯誤﹑更新延誤不負任何責任。